Clinical trial
NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by…
NCT00169611 · Hospices Civils de Lyon, Other · Completed
Key facts
| NCT number | NCT00169611 |
|---|---|
| Title | NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate |
| Official title | Comportemental and Neuropsychologic Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate. A Double-blind Randomised Study Methylphenidate Versus Placebo |
| Lead sponsor | Hospices Civils de Lyon, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Neurofibromatosis Type 1 |
| Intervention type | Drug |
| Interventions | methylphenidate |
| Enrollment | 80 |
| Start date | Jan 1, 2004 |
| Primary completion | Jan 1, 2011 |
| Completion | Jan 1, 2011 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 27, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: